Sackler Factor Could Sink Purdue's $8B Opioid Deal With DOJ
While the $8 billion criminal and civil settlement OxyContin maker Purdue Pharma made with the federal government resolves the Chapter 11 claim from its single largest creditor, it could draw fatal...To view the full article, register now.
Already a subscriber? Click here to view full article